Lonza has launched Ibex Solutions, biologics modular manufacturing capacity, at is site in Visp, Switzerland.

Construction began in June 2017 with a formal groundbreaking ceremony expected in the second half of 2017. Several hundred new positions are expected to be created.

Ibex biomanufacturing comprises a modular, technology-independent development and manufacturing complex capable of supporting activities across multiple technologies (mammalian, microbial, cellular or bioconjugate) from late discovery to manufacture.

The availability of a modular complex means time-to-market can be reduced by 12 months or more, according to information from Lonza.

Source: Lonza